Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal
<p>Abstract</p> <p>Mounting evidence suggests that there is frequently considerable variation in the risk of the outcome of interest in clinical trial populations. These differences in risk will often cause clinically important heterogeneity in treatment effects (HTE) across the tr...
Main Authors: | Kent David M, Rothwell Peter M, Ioannidis John PA, Altman Doug G, Hayward Rodney A |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-08-01
|
Series: | Trials |
Online Access: | http://www.trialsjournal.com/content/11/1/85 |
Similar Items
-
Competing risk and heterogeneity of treatment effect in clinical trials
by: Alsheikh-Ali Alawi, et al.
Published: (2008-05-01) -
Lead editorial: Trials – using the opportunities of electronic publishing to improve the reporting of randomised trials
by: Grimshaw Jeremy M, et al.
Published: (2006-03-01) -
Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis
by: Kent David M, et al.
Published: (2006-04-01) -
Determinants of patient recruitment in a multicenter clinical trials group: trends, seasonality and the effect of large studies
by: Ioannidis John PA, et al.
Published: (2001-06-01) -
Effectiveness of antidepressants: an evidence myth constructed from a thousand randomized trials?
by: Ioannidis John PA
Published: (2008-05-01)